JPS57192344A - 1-alkyl-2-aminotetralin derivative - Google Patents

1-alkyl-2-aminotetralin derivative

Info

Publication number
JPS57192344A
JPS57192344A JP57075554A JP7555482A JPS57192344A JP S57192344 A JPS57192344 A JP S57192344A JP 57075554 A JP57075554 A JP 57075554A JP 7555482 A JP7555482 A JP 7555482A JP S57192344 A JPS57192344 A JP S57192344A
Authority
JP
Japan
Prior art keywords
carbon atoms
group
alkyl group
alkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57075554A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0419221B2 (show.php
Inventor
Rarusuueriiku Aabuitsu Fuoruke
Aabuitsudo Emiiru Kaaruso Peru
Arufu Hatsukuseru Uri
Sutefuan Mikaeru Iyotsuto Yoon
Marugareeta Yohanson Anetsute
Renaato Rindoberui Peru
Rarusu Gunnaa Niruson Yoon
Sanshiesu Domingo
Buiruherumu Buikusutori Hookan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of JPS57192344A publication Critical patent/JPS57192344A/ja
Publication of JPH0419221B2 publication Critical patent/JPH0419221B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP57075554A 1981-05-08 1982-05-07 1-alkyl-2-aminotetralin derivative Granted JPS57192344A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8102908 1981-05-08

Publications (2)

Publication Number Publication Date
JPS57192344A true JPS57192344A (en) 1982-11-26
JPH0419221B2 JPH0419221B2 (show.php) 1992-03-30

Family

ID=20343779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57075554A Granted JPS57192344A (en) 1981-05-08 1982-05-07 1-alkyl-2-aminotetralin derivative

Country Status (16)

Country Link
US (1) US4876284A (show.php)
EP (1) EP0064964B1 (show.php)
JP (1) JPS57192344A (show.php)
AT (1) ATE8874T1 (show.php)
AU (2) AU554206B2 (show.php)
CA (1) CA1236113A (show.php)
DE (1) DE3260529D1 (show.php)
DK (1) DK164937C (show.php)
ES (4) ES8306708A1 (show.php)
FI (1) FI78067C (show.php)
GR (1) GR77121B (show.php)
IE (1) IE53143B1 (show.php)
IL (1) IL65501A (show.php)
NO (1) NO152902C (show.php)
NZ (1) NZ200526A (show.php)
PH (2) PH18065A (show.php)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04505618A (ja) * 1989-05-31 1992-10-01 ジ・アップジョン・カンパニー 治療学的に有用な2―アミノテトラリン誘導体

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
US4657925A (en) * 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US4743618A (en) * 1983-01-03 1988-05-10 Nelson Research & Development Co. Substituted 2-aminotetralins
US4722933A (en) * 1985-12-20 1988-02-02 Nelson Research & Development Co. Substituted 2-aminotetralins
GB2157950B (en) * 1984-05-04 1988-11-02 Nelson Res & Dev Selective d-2 dopamine receptor agonist
AU573828B2 (en) * 1984-05-17 1988-06-23 E.R. Squibb & Sons, Inc. Tetrahydronaphthalenols
EP0168505B1 (en) * 1984-05-22 1989-08-09 Whitby Research Incorporated Substituted 2-aminotetralins and processes for synthesis
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
EP0451145A1 (en) * 1988-07-29 1991-10-16 Schering Corporation A PROCESS FOR THE ENANTIOSPECIFIC SYNTHESIS OF INTERMEDIATES FOR HEXAHYDRO-BENZO d]NAPHTHO 2,1-b]AZEPINES
US5091526A (en) * 1988-07-29 1992-02-25 Schering Corporation Process for the enantiospecific synthesis of intermediates for hexahydro-benzo[d]-naphtho[2,1-b]azepines
CA1335106C (en) * 1989-02-27 1995-04-04 John Mehnert Schaus Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
IT1232160B (it) * 1989-07-31 1992-01-25 Sigma Tau Ind Farmaceuti 2-(n-acil)ammino-6,7-dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono
EP0507863A4 (en) * 1989-12-28 1993-07-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof
EP0471515B1 (en) * 1990-08-15 1997-03-05 Eli Lilly And Company Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes
AU1915192A (en) * 1991-04-26 1992-12-21 Upjohn Company, The Method of treating/preventing substance abuse using 1-alkyl-5(substituted oxy)-2-aminotetralins
PT100639A (pt) * 1991-06-27 1993-09-30 Univ Virginia Commonwealth Metodo para o tratamento terapeutico com compostos que sao ligandos ao receptor sigma e compostos ai utilizados, nomeadamente derivados fenilalquil-amina, aminotetralina,piperazina e piperidina
IT1251877B (it) * 1991-09-26 1995-05-26 Zambon Spa Processo per la preparazione di 2-ammino-5,6 dimetossi-tetralina
WO1994022495A1 (en) * 1993-03-31 1994-10-13 The Trustees Of The University Of Pennsylvania Dopamine d-3 and serotonin (5-ht1a) receptor ligands and imaging agents
EP0714292A4 (en) * 1993-06-23 1996-10-09 Cambridge Neuroscience Inc SIGMA RECEPTOR LIGANDS AND THEIR USE
GB9315566D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Medicaments
US6008219A (en) * 1995-03-27 1999-12-28 Smithkline Beech P.L.C. Bicyclic amine derivatives and their use as anti-psychotic agents
US5646188A (en) * 1995-07-05 1997-07-08 Teva Pharmaceutical Industries, Ltd. Polyamine derivatives of 1-aminoindan
NZ510988A (en) * 1998-10-07 2005-01-28 Ortho Mcneil Pharm Inc N-aralkylaminotetralins useful as ligands for the neuropeptide Y5 receptor
CA2486092A1 (en) 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
DE102010020553A1 (de) 2010-05-14 2011-11-17 Bayer Schering Pharma Aktiengesellschaft Substituierte 8-Alkoxy-2-aminotetralin-Derivate und ihre Verwendung
CN104703964B (zh) 2012-07-20 2017-04-12 拜耳制药股份公司 取代氨基茚满‑和氨基萘满甲酸及其用途
SG11201408421TA (en) 2012-07-20 2015-02-27 Bayer Pharma AG Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
JP2025502842A (ja) 2021-12-29 2025-01-28 バイエル アクツィエンゲゼルシャフト 薬学的に活性な化合物としての使用のための(5s)-{[2-(4-カルボキシフェニル)エチル][2-(2-{[3-クロロ-4’-(トリフルオロメチル)ビフェニル-4-イル]メトキシ}フェニル)エチル]アミノ}-5,6,7,8-テトラヒドロキノリン-2-カルボン酸及びその結晶形態を調製するための方法
AU2022424376A1 (en) 2021-12-29 2024-07-04 Bayer Aktiengesellschaft Treatment of cardiopulmonary disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1017359A (en) * 1972-07-03 1977-09-13 Frederic P. Hauck Substituted cyclic polymethylene phenols
JPS5124508B2 (show.php) * 1972-08-14 1976-07-24
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
DE3062971D1 (en) * 1979-09-14 1983-06-09 Sandoz Ag Derivatives of tetraline, their preparation and medicaments containing these compounds
AU7179781A (en) * 1980-05-29 1981-12-21 Astra Lakemedel Aktiebolag Therapeutically useful tetralin derivatives
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
FR2512814A1 (fr) * 1981-09-16 1983-03-18 Synthelabo Derives d'amino-2 tetrahydro-1,2,3,4 naphtalene, leur preparation et leur application en therapeutique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04505618A (ja) * 1989-05-31 1992-10-01 ジ・アップジョン・カンパニー 治療学的に有用な2―アミノテトラリン誘導体

Also Published As

Publication number Publication date
IE821076L (en) 1982-11-08
NZ200526A (en) 1985-09-13
AU2587984A (en) 1984-06-28
FI821598L (fi) 1982-11-09
FI78067B (fi) 1989-02-28
NO152902C (no) 1985-12-11
DK202882A (da) 1982-11-09
CA1236113A (en) 1988-05-03
AU8340982A (en) 1982-11-11
FI78067C (fi) 1989-06-12
US4876284A (en) 1989-10-24
GR77121B (show.php) 1984-09-07
ES8602603A1 (es) 1985-12-01
DK164937C (da) 1993-02-01
PH18065A (en) 1985-03-18
AU554206B2 (en) 1986-08-14
EP0064964A1 (en) 1982-11-17
PH19585A (en) 1986-05-26
ES511986A0 (es) 1983-06-01
ES8504666A1 (es) 1985-05-01
IE53143B1 (en) 1988-07-20
DE3260529D1 (en) 1984-09-13
ATE8874T1 (de) 1984-08-15
NO152902B (no) 1985-09-02
ES529311A0 (es) 1985-08-01
JPH0419221B2 (show.php) 1992-03-30
ES535882A0 (es) 1985-12-01
ES8506591A1 (es) 1985-08-01
AU572497B2 (en) 1988-05-12
DK164937B (da) 1992-09-14
ES8306708A1 (es) 1983-06-01
NO821494L (no) 1982-11-09
IL65501A (en) 1986-04-29
IL65501A0 (en) 1982-07-30
ES519615A0 (es) 1985-05-01
FI821598A0 (fi) 1982-05-06
EP0064964B1 (en) 1984-08-08

Similar Documents

Publication Publication Date Title
JPS57192344A (en) 1-alkyl-2-aminotetralin derivative
ES8400730A1 (es) Un procedimiento para preparar derivados de tetralina
GB2251616B (en) Therapeutic benzazapine compounds
NO823125L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-amino-naftalen-derivater
DE3362876D1 (en) Dibenzocycloheptenylidene compounds for use in modulating the immune response
MY108455A (en) Therapeutic benzazapine compounds.